ature and mechanisms of cognitive deficits following chemotherapy: an (f)MRI study - chemotherapy, cognition and (f)MRI

Antoni van Leeuwenhoek Ziekenhuis0 个研究点目标入组 180 人开始时间: 待定最近更新: 2024年8月12日

适应症

试验速览

暂无简介。

•All groups:
•-female, independent of menopausal status
•-age under 70 years (to allow use of the same neuropsychological test battery)
•-sufficient proficiency in the Dutch language;Experimental group:
•-newly diagnosed breast cancer patients without distant metastases who will receive anthracycline-based chemotherapy ;Breast cancer control group:
•-newly diagnosed breast cancer patients without distant metastases who do not require chemotherapy;Healthy control group:
•-healthy females, matched for age

•All groups:
•-previous malignancies
•-excessive use of alcohol or drugs
•-use of psychotropic medication
•-neurologic or psychiatric disorders that may influence cognitive functioning
•-conditions that preclude MRI examination.;Experimental group and breast cancer control group:
•-relapse and/or metastases
•- treatment with trastuzumab (Herceptin)

发起方

Antoni van Leeuwenhoek Ziekenhuis